These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2644581)

  • 1. Nifedipine in the prophylaxis of classic migraine: a crossover, double-masked, placebo-controlled study of headache frequency and side effects.
    McArthur JC; Marek K; Pestronk A; McArthur J; Peroutka SJ
    Neurology; 1989 Feb; 39(2 Pt 1):284-6. PubMed ID: 2644581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine in migraine and tension headache: a randomised double blind crossover study.
    Shukla R; Garg RK; Nag D; Ahuja RC
    J Assoc Physicians India; 1995 Nov; 43(11):770-2. PubMed ID: 8773038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nifedipine versus propranolol for the initial prophylaxis of migraine.
    Albers GW; Simon LT; Hamik A; Peroutka SJ
    Headache; 1989 Apr; 29(4):215-8. PubMed ID: 2654067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon.
    Gjørup T; Kelbaek H; Hartling OJ; Nielsen SL
    Am Heart J; 1986 Apr; 111(4):742-5. PubMed ID: 3513504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy between flunarizine and nifedipine in the prophylaxis of migraine.
    Lamsudin R; Sadjimin T
    Headache; 1993 Jun; 33(6):335-8. PubMed ID: 8349477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verapamil prophylaxis of migraine. A double-blind, placebo-controlled study.
    Solomon GD; Steel JG; Spaccavento LJ
    JAMA; 1983 Nov; 250(18):2500-2. PubMed ID: 6355533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind placebo-controlled trial of indobufen in the prophylaxis of migraine.
    Carrieri PB; Orefice G; Sorge F
    Acta Neurol Scand; 1988 Jun; 77(6):433-6. PubMed ID: 3043994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of nimodipine in the prophylaxis of migraine.
    Havanka-Kanniainen H; Hokkanen E; Myllylä VV
    Cephalalgia; 1985 Mar; 5(1):39-43. PubMed ID: 3886153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind controlled study of nifedipine as an abortive treatment in acute attacks of migraine with aura.
    Hoffert MJ; Scholz MJ; Kanter R
    Cephalalgia; 1992 Oct; 12(5):323-4. PubMed ID: 1423566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-5-hydroxytryptophan versus placebo in childhood migraine prophylaxis: a double-blind crossover study.
    Santucci M; Cortelli P; Rossi PG; Baruzzi A; Sacquegna T
    Cephalalgia; 1986 Sep; 6(3):155-7. PubMed ID: 3533271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis.
    Gerber WD; Diener HC; Scholz E; Niederberger U
    Cephalalgia; 1991 Feb; 11(1):37-45. PubMed ID: 2036669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.
    Sorge F; De Simone R; Marano E; Nolano M; Orefice G; Carrieri P
    Cephalalgia; 1988 Mar; 8(1):1-6. PubMed ID: 3282670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind study of naproxen vs placebo in the treatment of acute migraine attacks.
    Andersson PG; Hinge HH; Johansen O; Andersen CU; Lademann A; Gøtzsche PC
    Cephalalgia; 1989 Mar; 9(1):29-32. PubMed ID: 2650879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials.
    Diener HC; Scholz E; Dichgans J; Gerber WD; Jäck A; Bille A; Niederberger U
    Ann Neurol; 1989 Feb; 25(2):125-30. PubMed ID: 2645824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papaverine in the prophylaxis of migraine and other vascular headache in children.
    Sillanpää M; Koponen M
    Acta Paediatr Scand; 1978 Mar; 67(2):209-12. PubMed ID: 343489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quantification of the placebo response in migraine prophylaxis.
    van der Kuy PH; Lohman JJ
    Cephalalgia; 2002 May; 22(4):265-70. PubMed ID: 12100088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonidine in the prophylaxis of migraine.
    Boisen E; Deth S; Hübbe P; Jansen J; Klee A; Leunbach G
    Acta Neurol Scand; 1978 Nov; 58(5):288-95. PubMed ID: 367043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo.
    Zeeberg I; Orholm M; Nielsen JD; Honore PL; Larsen JJ
    Acta Neurol Scand; 1981 Dec; 64(6):452-9. PubMed ID: 6753446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine as a therapeutic alternative in migraine prophylaxis: a randomized, placebo-controlled, double-blind study.
    Guerrero RO; Cárdenas MA; Ocampo AA; Pacheco MF
    Headache; 1999 Sep; 39(8):576-80. PubMed ID: 11279974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.